Gaggioli G, Bottoni N, Brignole M, Menozzi C, Lolli G, Oddone D, Gianfranchi L
Laboratorio di Elettrofisiologia ed Impianto di Pacemaker, Ospedali Riuniti di Lavagna, Genova.
G Ital Cardiol. 1994 Apr;24(4):409-16.
Patients with bundle branch block and syncope, especially those with abnormal electrophysiologic study, are at high risk of progression to second-or third-degree atrioventricular block and therefore they often receive a permanent back-up pacemaker. The aim of this study was to evaluate of the incidence of bundle branch block progression to second or third-degree atrioventricular block during long-term follow-up.
A retrospective study was performed on 60 patients (49 males, age 77 +/- 9 years) with bundle branch block and permanent back-up pacemaker. The patients were subdivided into 3 groups: 13 patients, at pre-implant electrophysiologic study had HV interval > or = 100 msec and/or second- or third-degree atrioventricular block induced by ajmaline i.v. administration (Group 1); 20 patients with HV interval of 70-100 msec and/or HV > or = 120 msec after ajmaline administration (Group 2); 27 patients who had received a permanent pacemaker because of carotid sinus syndrome or sick sinus syndrome (22 patients) or because of recurrent syncopes and negative electrophysiologic study (5 patients) (Group 3).
During a mean follow-up of 62 +/- 41 months, 17/60 patients (28%) had progression to second- (n = 4) or third-degree (n = 13) atrioventricular block: atrioventricular block occurred in 54% of Group 1 patients in 25% of Group 2 patients and in 19% of Group 3 patients. The actuarial rate of progression to atrioventricular block for the overall population was, at 5 and 10 years, 25% and 58% respectively; in Group 1 it was 46% and 62%; in Group 2 it was 22% and 55% and in Group 3 it was 21% and 59% (p = 0.06). The patients with right bundle branch block and left anterior hemiblock were at higher risk of progression to atrioventricular block than those with right bundle branch block or left bundle branch block (risk 42% vs 14%, p = 0.06). The presence of an abnormal electrophysiologic study did not increase the progression rate either in the patients with right bundle branch block and left anterior hemiblock (risk of 43%), nor did it in those patients with other types of bundle branch block (risk of 18%). Moreover, the induction of second- or third-degree atrioventricular block during ajmaline administration was associated with a higher risk of block during the follow-up (60% vs 25%, p = 0.06).
Patients treated with pacemaker because of symptomatic bundle branch block have a high risk of progression to second- or third-degree atrioventricular block in the long-term follow-up. The results argue against the practical usefulness of electrophysiological study since a risk stratification could be obtained by the simpler surface electrocardiogram; moreover, risk of block was also present in the patients affected by carotid sinus syndrome or sick sinus syndrome, and in those affected by unexplained syncope with negative electrophysiologic study.
患有束支传导阻滞和晕厥的患者,尤其是那些电生理检查异常的患者,进展为二度或三度房室传导阻滞的风险很高,因此他们经常接受永久性备用起搏器治疗。本研究的目的是评估长期随访期间束支传导阻滞进展为二度或三度房室传导阻滞的发生率。
对60例患有束支传导阻滞并植入永久性备用起搏器的患者(49例男性,年龄77±9岁)进行了一项回顾性研究。患者被分为3组:13例患者,植入前电生理检查时HV间期≥100毫秒和/或静脉注射阿义马林诱发二度或三度房室传导阻滞(第1组);20例患者HV间期为70 - 100毫秒和/或注射阿义马林后HV≥120毫秒(第2组);27例因颈动脉窦综合征或病态窦房结综合征(22例)或因反复晕厥且电生理检查阴性(5例)而接受永久性起搏器治疗的患者(第3组)。
在平均62±41个月的随访期间,60例患者中有17例(28%)进展为二度(n = 4)或三度(n = 13)房室传导阻滞:第1组患者中54%发生房室传导阻滞,第2组患者中25%发生,第3组患者中19%发生。总体人群进展为房室传导阻滞的累积发生率在5年和10年时分别为25%和58%;第1组为46%和62%;第2组为22%和55%;第3组为21%和59%(p = 0.06)。右束支传导阻滞合并左前分支阻滞的患者进展为房室传导阻滞的风险高于右束支传导阻滞或左束支传导阻滞的患者(风险分别为42%对14%,p = 0.06)。电生理检查异常在右束支传导阻滞合并左前分支阻滞的患者中(风险为43%)或在其他类型束支传导阻滞的患者中(风险为18%)均未增加进展率。此外,静脉注射阿义马林期间诱发二度或三度房室传导阻滞与随访期间更高的阻滞风险相关(60%对25%,p = 0.06)。
因有症状的束支传导阻滞而接受起搏器治疗的患者在长期随访中有进展为二度或三度房室传导阻滞的高风险。结果表明电生理检查的实际用处不大,因为通过更简单的体表心电图即可进行风险分层;此外,颈动脉窦综合征或病态窦房结综合征患者以及电生理检查阴性的不明原因晕厥患者也存在阻滞风险。